Air pollution can adversely affect the immune response and increase the severity of the viral
disease. The present study aimed to explore the relationship between symptomatology, …

Long-term analyses of demographical and clinical characteristics of COVID-19 patients can
provide a better overview of the clinical course of the disease. They can also help …

Because the optimal treatment for COVID-19 is still unknown, it is important to explore every
potential way of improving the chances of survival for COVID-19 patients. The aim of the …

Background: Patients with kidney failure are at an increased risk of progression to a severe
form of coronavirus disease 2019 (COVID-19) with high mortality. The current analysis was …

Background Remdesivir (RDV) is the only antiviral drug registered currently for treatment of
COVID-19 after a few clinical trials with controversial results. The purpose of this study was to …

Despite direct viral effect, the pathogenesis of coronavirus disease 2019 (COVID-19) includes
an overproduction of cytokines including interleukin 6 (IL-6). Therefore, tocilizumab (TOC), …

Simple Summary Patients with active malignancies have an increased risk for severe SARS-CoV-2
infection and high mortality from COVID-19. Additionally, due to the underlying …

Purpose The pathogenesis of coronavirus disease 2019 (COVID-19) is complicated, and in
addition to antiviral therapy and combating coagulopathy, treatment should also include …

Simple Summary Hepatitis C virus (HCV) is the major factor responsible for hepatocellular
carcinoma (HCC). Currently available treatments for HCV infection are short, simple, effective …

Patients with systemic autoimmune rheumatic disease (SARD) have increased susceptibility
to viral infections, including SARS-CoV-2. The aim of this study was to analyse the SARD …